Skip to main content
SpringerLink
Log in

Feasibility and Efficacy of Combination Therapy With Preoperative and Postoperative Chemoradiation, Extended Pancreatectomy, and Postoperative Liver Perfusion Chemotherapy for Locally Advanced Cancers of the Pancreatic Head

  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

The outcome after resection of advanced pancreatic cancers is extremely poor because of the high incidence of the postoperative development of liver metastasis and local recurrence. We performed a combination of chemoradiation and liver perfusion chemotherapy and extended pancreatectomy.

Methods

Nineteen patients with T3 pancreatic head cancers were enrolled. A total of 24 Gy in 12 fractions of 10-MV x-rays with a concurrent intravenous infusion of 5-fluorouracil (5-FU; 3 g/12 days) was administered to the pancreatic head area. An extended pancreaticoduodenectomy was performed, and catheters were placed into the gastroduodenal artery and the superior mesenteric vein. During the first 28 postoperative days, 5-FU was continuously infused via the hepatic artery and portal vein (3.5 g/28 days × 2). Finally, 36 Gy in 18 fractions with 5-FU (3 g/6 days) was applied to the pancreatic bed.

Results

After preoperative chemoradiation, four patients did not undergo surgical resection because of distant metastases. Fifteen patients underwent pancreaticoduodenectomy, liver perfusion chemotherapy, and postoperative chemoradiation. No patient developed grade 3 toxicity as a result of preoperative chemoradiation, but one patient (7%) developed grade 3 leukopenia during the postoperative treatments. The morbidity rate was 20% (3 of 15 patients), and the mortality rate was 0%. The overall 3-year survival rate was 53%. The 3-year disease-free survival rate was 66% in patients who pathologically responded well (>50%), versus 0% in patients with poor responses (P = .04).

Conclusions

A combination of preoperative and postoperative chemoradiation plus postoperative liver perfusion chemotherapy with an extended pancreatectomy is feasible, and the long-term outcomes are also promising.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Nitecki SS, Sarr MG, Colby TV, et al. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 1995;221:59–66

    Google Scholar 

  2. Sperti C, Pasquali C, Piccoli A, et al. Survival after resection for ductal adenocarcinoma of the pancreas. Br J Surg 1996;83:625–31

    Google Scholar 

  3. Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg 1995;221:721–31; discussion 731–3

    Google Scholar 

  4. Manabe T, Ohshio G, Baba N, et al. Radical pancreatectomy for ductal cell carcinoma of the head of the pancreas. Cancer 1989;64:1132–7

    Google Scholar 

  5. Ishikawa O, Ohhigashi H, Sasaki Y, et al. Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head. Ann Surg 1988;208:215–20

    Google Scholar 

  6. Willett CG, Lewandrowski K, Warshaw AL, et al. Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy. Ann Surg 1993;217:144–8

    Google Scholar 

  7. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group. Cancer 1987;59:2006–10

    Google Scholar 

  8. Spitz FR, Abbruzzese JL, Lee JE, et al. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol 1997;15:928–37

    Google Scholar 

  9. Breslin TM, Hess KR, Harbison DB, et al. Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. Ann Surg Oncol 2001;8:123–32

    Google Scholar 

  10. Hoffman JP, Lipsitz S, Pisansky T, et al. Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study. J Clin Oncol 1998;16:317–23

    Google Scholar 

  11. Yeo CJ, Abrams RA, Grochow LB, et al. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann Surg 1997;225:621–33

    Google Scholar 

  12. Evans DB, Abbruzzese JL, Cleary KR, et al. Preoperative chemoradiation for adenocarcinoma of the pancreas: excessive toxicity of prophylactic hepatic irradiation. Int J Radiat Oncol Biol Phys 1995;33:913–8

    Google Scholar 

  13. Ishikawa O, Ohigashi H, Sasaki Y, et al. Intraoperative cytodiagnosis for detecting a minute invasion of the portal vein during pancreatoduodenectomy for adenocarcinoma of the pancreatic head. Am J Surg 1998;175:477–81

    Google Scholar 

  14. Ishikawa O, Ohigashi H, Sasaki Y, et al. Liver perfusion chemotherapy via both the hepatic artery and portal vein to prevent hepatic metastasis after extended pancreatectomy for adenocarcinoma of the pancreas. Am J Surg 1994;168:361–4

    Google Scholar 

  15. Ishikawa O, Ohigashi H, Yamada T, et al. Adjuvant regional infusion therapy: a two-channel chemotherapy to prevent hepatic metastasis after extended pancreatectomy for adenocarcinoma of the pancreas—the Osaka experience. In: Evans DB, Pisters PW, Abbruzzese JL, eds. Pancreatic Cancer. New York: Springer, 2001:269–74

    Google Scholar 

  16. Trotti A, Colevas AD, Setser A, et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003;13:176–81

    Google Scholar 

  17. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;185:1457–81

    Google Scholar 

  18. Pellegrini CA, Heck CF, Raper S, et al. An analysis of the reduced morbidity and mortality rates after pancreaticoduodenectomy. Arch Surg 1989;124:778–81

    Google Scholar 

  19. Grace PA, Pitt HA, Tompkins RK, et al. Decreased morbidity and mortality after pancreatoduodenectomy. Am J Surg 1986;151:141–9

    Google Scholar 

  20. Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 1997;226:248–57

    Google Scholar 

  21. Evans DB, Rich TA, Byrd DR, et al. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg 1992;127:1335–9

    Google Scholar 

  22. Neoptolemos JP, Stocken DD, Dunn JA, et al. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg 2001;234:758–68

    Google Scholar 

  23. Yeung RS, Weese JL, Hoffman JP, et al. Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A phase II study. Cancer 1993;72:2124–33

    Google Scholar 

  24. Staley CA, Lee JE, Cleary KR, et al. Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. Am J Surg 1996;171:118–24

    Google Scholar 

  25. White RR, Hurwitz HI, Morse MA, et al. Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas Ann Surg Onco 2001;l8: 758–65

    Google Scholar 

  26. Pendurthi TK, Hoffman JP, Ross E, et al. Preoperative versus postoperative chemoradiation for patients with resected pancreatic adenocarcinoma. Am Surg 1998;64:686–92

    Google Scholar 

  27. Shimoyama M, Kimura K. Cytocidal effects of anticancer drugs. In vitro assay with L-1210. Saisinn Igaku 1973;28:1024–40

    Google Scholar 

  28. Ackerman NB. The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth. Surgery 1974;75:589–96

    Google Scholar 

  29. Beger HG, Gansauge F, Buchler MW, et al. Intraarterial adjuvant chemotherapy after pancreaticoduodenectomy for pancreatic cancer: significant reduction in occurrence of liver metastasis. World J Surg 1999;23:946–9

    Google Scholar 

  30. Picozzi VJ, Kozarek RA, Traverso LW. Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am J Surg 2003;185:476–80

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, 1-3-3 Nakamichi, Higashinari-ku, Osaka, 537-8511, Japan

    Hiroaki Ohigashi MD, Osamu Ishikawa MD, Hidetoshi Eguchi MD, Yo Sasaki MD, Terumasa Yamada MD, Shingo Noura MD, Kohei Murata MD, Ko Takachi MD, Isao Miyashiro MD, Yuichiro Doki MD & Shingi Imaoka MD

  2. Department of Pathology, Osaka Medical Center for Cancer and Cardiovascular Diseases, 1-3-3 Nakamichi, Higashinari-ku, Osaka, 537-8511, Japan

    Tsutomu Kasugai MD

  3. Department of Radiotherapy, Osaka Medical Center for Cancer and Cardiovascular Diseases, 1-3-3 Nakamichi, Higashinari-ku, Osaka, 537-8511, Japan

    Kinji Nishiyama MD

Authors
  1. Hiroaki Ohigashi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Osamu Ishikawa MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hidetoshi Eguchi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yo Sasaki MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Terumasa Yamada MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shingo Noura MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kohei Murata MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ko Takachi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Isao Miyashiro MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Yuichiro Doki MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Shingi Imaoka MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Tsutomu Kasugai MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Kinji Nishiyama MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hiroaki Ohigashi MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ohigashi, H., Ishikawa, O., Eguchi, H. et al. Feasibility and Efficacy of Combination Therapy With Preoperative and Postoperative Chemoradiation, Extended Pancreatectomy, and Postoperative Liver Perfusion Chemotherapy for Locally Advanced Cancers of the Pancreatic Head. Ann Surg Oncol 12, 629–636 (2005). https://doi.org/10.1245/ASO.2005.05.028

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/ASO.2005.05.028

Key Words

Search

Navigation